SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/403A075816017551473FD17EA1EC11B89C5AFC071D88DE319027100DA2C6013F2924D5A26EE80C6AEC60397128BE2A9E>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/403A075816017551473FD17EA1EC11B89C5AFC071D88DE319027100DA2C6013F2924D5A26EE80C6AEC60397128BE2A9E
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/403A075816017551473FD17EA1EC11B89C5AFC071D88DE319027100DA2C6013F2924D5A26EE80C6AEC60397128BE2A9E
http://www.w3.org/2000/01/rdf-schema#comment
"GSK3B is significantly more activated in drug-resistant versus responsive patients."
xsd:string
http://purl.uniprot.org/uniprot/#_AAFE619D18C8ECB478545AE42D05977F3A986A43ABBB78EC5D2EF62878B5F9C0D3ECC9EC8AE72316DC958723509EEA1B
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/403A075816017551473FD17EA1EC11B89C5AFC071D88DE319027100DA2C6013F2924D5A26EE80C6AEC60397128BE2A9E
http://purl.uniprot.org/uniprot/A0A3B3ITW1
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/403A075816017551473FD17EA1EC11B89C5AFC071D88DE319027100DA2C6013F2924D5A26EE80C6AEC60397128BE2A9E
http://purl.uniprot.org/uniprot/#_A0A3B3ITW1-mappedCitation-23729362
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/403A075816017551473FD17EA1EC11B89C5AFC071D88DE319027100DA2C6013F2924D5A26EE80C6AEC60397128BE2A9E